Consolidated Condensed Statements of Cash Flows
Nine Months Ended |
||||
(In Millions; unaudited) |
Oct 1, 2022 |
Sep 25, 2021 |
||
Cash and cash equivalents, beginning of period |
$ 4,827 |
$ 5,865 |
||
Cash flows provided by (used for) operating activities: |
||||
Net income |
8,678 |
15,245 |
||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||
Depreciation |
8,309 |
7,357 |
||
Share-based compensation |
2,392 |
1,587 |
||
Restructuring and other charges |
665 |
2,597 |
||
Amortization of intangibles |
1,439 |
1,361 |
||
(Gains) losses on equity investments, net |
(4,075) |
(1,113) |
||
(Gains) losses on divestitures |
(1,072) |
— |
||
Changes in assets and liabilities: |
||||
Accounts receivable |
1,991 |
(1,618) |
||
Inventories |
(2,043) |
(1,212) |
||
Accounts payable |
(485) |
1,095 |
||
Accrued compensation and benefits |
(1,912) |
(16) |
||
Prepaid customer supply agreements |
(18) |
(1,577) |
||
Income taxes |
(4,062) |
(570) |
||
Other assets and liabilities |
(2,077) |
917 |
||
Total adjustments |
(948) |
8,808 |
||
Net cash provided by operating activities |
7,730 |
24,053 |
||
Cash flows provided by (used for) investing activities: |
||||
Additions to property, plant and equipment |
(19,145) |
(11,579) |
||
Additions to held for sale NAND property, plant and equipment |
(206) |
(1,118) |
||
Purchases of short-term investments |
(31,669) |
(30,326) |
||
Maturities and sales of short-term investments |
35,129 |
22,270 |
||
Sales of equity investments |
4,880 |
444 |
||
Proceeds from divestitures |
6,579 |
— |
||
Other investing |
(2,614) |
766 |
||
Net cash used for investing activities |
(7,046) |
(19,543) |
||
Cash flows provided by (used for) financing activities: |
||||
Payments on finance leases |
(341) |
— |
||
Issuance of long-term debt, net of issuance costs |
6,103 |
4,974 |
||
Repayment of debt |
(3,088) |
(500) |
||
Proceeds from sales of common stock through employee equity incentive plans |
972 |
1,016 |
||
Repurchase of common stock |
— |
(2,415) |
||
Payment of dividends to stockholders |
(4,488) |
(4,231) |
||
Other financing |
(140) |
(1,349) |
||
Net cash used for financing activities |
(982) |
(2,505) |
||
Net increase (decrease) in cash and cash equivalents |
(298) |
2,005 |
||
Cash and cash equivalents, end of period |
$ 4,529 |
$ 7,870 |